J Alfred Broaddus Jr
CIK 1298933 · last filed 2018-05-16
J Alfred Broaddus Jr is a corporate insider who has filed 150 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MKL, was dated May 16, 2018. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.1M across reported positions. 18 SEC filings were submitted jointly with MARKEL GROUP INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TROW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MECHANICSVILLE, VA 23116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MKL | Director | 2,337 | $1858.62 | $4.35M | $0 | 5 | 2018-05-16 |
| ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Director | — | $2.80 | — | $0 | 73 | 2013-04-29 |
| TROW | Director | 23,815 | $103.63 | $2.47M | -$1.19M | 37 | 2013-03-28 |
| MARKEL GROUP INC. (MKV) Delisted | Director | 1,541 | — | — | -$124.8K | 7 | 2012-05-16 |
| ALB | Director | 3,225 | $98.96 | $319.1K | $0 | 28 | 2012-04-04 |
Recent Filings
150 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-16 | MKL | Grant (A) | +110 | $0 | EDGAR |
| 2017-05-16 | MKL | Grant (A) | +105 | $0 | EDGAR |
| 2016-05-18 | MKL | Grant (A) | +105 | $0 | EDGAR |
| 2015-05-13 | MKL | Grant (A) | +129 | $0 | EDGAR |
| 2013-05-15 | MKL | Grant (A) | +190 | $0 | EDGAR |
| 2013-04-29 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-04-01 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-28 | TROW | Grant (A) | +80 | $5.9K | EDGAR |
| 2013-02-07 | TROW | Mixed | +7,874 | -$583.0K | EDGAR |
| 2013-02-01 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.